Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Gao (Helsinkiolm, Finland), T. Törölä (Helsinkiolm, Finland), C. Li (Stockholm, Sweden), S. Ohlmeier (Oulu, Finland), T. Toljamo (Rovaniemi, Finland), P. Nieminen (Ouluholm, Finland), N. Hattori (Hiroshima, Japan), V. Pulkkinen (Helsinki, Finland), H. Iwamoto (Hiroshima, Japan), W. Mazur (Helsinki, Finland). Sputum Vitamin D binding protein (VDBP) GC1S/1S genotype predicts airway obstruction: a prospective study in smokers with COPD. 962

Member's Comments

No comment yet.

Related content which might interest you: The relationship of vitamin D binding protein polymorphisms with blood vitamin D Level in Korean patients with COPD Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Plasma surfactant protein D (SP-D) and smoking status in patients with COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Serum vitamin D3 level correlates with FEV1 in patients with advanced COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study Source: Eur Respir J 2011; 38: 1320-1327 Year: 2011 Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD Source: International Congress 2014 – Predictors Year: 2014 The effect of Vitamin D deficiency on lung function in current smoker COPD patients Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Plasma surfactant protein D (SP-D) in patients (pts) with stable (S) COPD and during COPD acute exacerbation (AE) Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Relationship between vitamin A and inflammation in the sputum and serum of smokers and COPD patients Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Serum vitamin D levels and exercise-induced bronchoconstriction in children with asthma Source: Eur Respir J 2011; 37: 1366-1370 Year: 2011 Plasma surfactant protein-D (SPD) concentration and severity of airflow limitation in COPD patients (pts) Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Vitamin E supplement usage and pulmonary outcomes in COPDGene Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden Year: 2016 Vitamin C level in the serum of smokers and non-smokers with COPD in stable state and during exacerbation Source: Eur Respir J 2007; 30: Suppl. 51, 556s Year: 2007 Serum vitamin D level is associated with emphysema progression in male patients with COPD Source: International Congress 2017 – Markers of COPD progression Year: 2017 Vitamin D deficiency and COPD exacerbations: Effect of vitamin D supplementation Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Asthma control status and  lung function   in   relation to vitamin D level  in children with bronchial asthma. Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 Vitamin D status and longitudinal lung function decline in the Lung Health Study Source: Eur Respir J 2011; 37: 238 Year: 2011 Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Vitamin D, magnesium and calcium do not correlate with COPD: A cross-sectional study Source: Annual Congress 2013 –New issues in lung function testing Year: 2013